--- title: "TenNor Therapeutics Suzhou (6872) stock and investor profile" url: "https://aibio.space/companies/tennor-therapeutics-suzhou/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "TenNor Therapeutics Suzhou Ltd. (HKEX: 6872), China. The directory classifies it as Biotechnology." --- 6872 TenNor Therapeutics Suzhou Ltd. HKEX · China # TenNor Therapeutics Suzhou (6872) news TenNor Therapeutics Suzhou Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 6872, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest TenNor Therapeutics Suzhou news We have not published a story on TenNor Therapeutics Suzhou yet. When there is news, it will appear here. ## TenNor Therapeutics Suzhou at a glance - **Ticker**: 6872 - **Listing**: HKEX - **Country**: China ### Related companies - [Hanx Biopharmaceuticals (Wuhan) Co.](https://aibio.space/companies/hanx-biopharmaceuticals-wuhan/) HKEX: 3378 - [PegBio Co.](https://aibio.space/companies/pegbio/) HKEX: 2565 - [Sichuan Kelun Pharmaceutical Co.](https://aibio.space/companies/sichuan-kelun-pharmaceutical/) SZSE: 002422 - [JW (Cayman) Therapeutics Co.](https://aibio.space/companies/jw-cayman-therapeutics/) HKEX: 2126 - [Beijing Tiantan Biological Products Corporation](https://aibio.space/companies/beijing-tiantan-biological-products/) SSE: 600161 - [Shouyao Holdings Beijing Co.](https://aibio.space/companies/shouyao-beijing/) SSE: 688197 - [Hualan Biological Vaccine](https://aibio.space/companies/hualan-biological-vaccine/) SZSE: 301207 - [Shaanxi Micot Pharmaceutical Technology Co.](https://aibio.space/companies/shaanxi-micot-pharmaceutical-technology/) HKEX: 2335 ### Also on HKEX - [Hightide Therapeutics](https://aibio.space/companies/hightide-therapeutics/) 2511 - [Simcere Pharmaceutical Group](https://aibio.space/companies/simcere-pharmaceutical/) 2096 - [China Regenerative Medicine International](https://aibio.space/companies/china-regenerative-medicine-international/) 8158 - [Clover Biopharmaceuticals](https://aibio.space/companies/clover-biopharmaceuticals/) 2197 - [CPBIO Holding Company](https://aibio.space/companies/cpbio/) 3839 - [Sino Biopharmaceutical](https://aibio.space/companies/sino-biopharmaceutical/) 1177 ## Questions about TenNor Therapeutics Suzhou What is the ticker symbol of TenNor Therapeutics Suzhou? TenNor Therapeutics Suzhou Ltd. trades under the ticker 6872 on HKEX. Where is TenNor Therapeutics Suzhou listed? TenNor Therapeutics Suzhou Ltd. is listed on HKEX. Which country or territory is TenNor Therapeutics Suzhou listed under? Our directory records TenNor Therapeutics Suzhou Ltd. under China. What does TenNor Therapeutics Suzhou do? Our directory classifies TenNor Therapeutics Suzhou Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of TenNor Therapeutics Suzhou? The ISIN recorded for TenNor Therapeutics Suzhou Ltd. is CNE100007KG6. Does aibio.space cover TenNor Therapeutics Suzhou? aibio.space lists TenNor Therapeutics Suzhou Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to TenNor Therapeutics Suzhou? Companies in our directory listed in the same country and business area as TenNor Therapeutics Suzhou: Hanx Biopharmaceuticals (Wuhan) Co., PegBio Co., Sichuan Kelun Pharmaceutical Co., JW (Cayman) Therapeutics Co., Beijing Tiantan Biological Products Corporation, Shouyao Holdings Beijing Co.. ## Investor discussion: TenNor Therapeutics Suzhou Members talk about TenNor Therapeutics Suzhou (6872). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at TenNor Therapeutics Suzhou, newest first. Each line links the filing it comes from. 1. 2026-10-02 Financings Share or debt issue: CIRCULAR OF 2026 SECOND EXTRAORDINARY GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1002/2026100201378.pdf) 2. 2026-05-13 Financings Share or debt issue: GLOBAL OFFERING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0514/2026051400013.pdf) ## Press releases Headlines of TenNor Therapeutics Suzhou's own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-10-26 HKEXnews [VOLUNTARY ANNOUNCEMENT H SHARE REPURCHASE PLAN](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1026/2026102600436.pdf) 2. 2026-10-23 HKEXnews [Articles of Association](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1023/2026102301369.pdf) 3. 2026-10-23 HKEXnews [POLL RESULTS OF THE 2026 SECOND EXTRAORDINARY GENERAL MEETING HELD ON FRIDAY, OCTOBER 23, 2026 AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1023/2026102301310.pdf) 4. 2026-10-23 HKEXnews [VOLUNTARY ANNOUNCEMENT COMPLETION OF ENROLLMENT OF THE FIRST PATIENT IN THE MULTI-CENTER PHASE IIB CLINICAL TRIAL OF RIFAQUIZINONE (TNP-2092) ADMINISTERED VIA INTRA-ARTICULAR INJECTION FOR THE TREATMENT OF PROSTHETIC JOINT INFECTION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1023/2026102300051.pdf) 5. 2026-10-02 HKEXnews [NOTICE OF 2026 SECOND EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1002/2026100201472.pdf) 6. 2026-10-02 HKEXnews [CIRCULAR OF 2026 SECOND EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1002/2026100201378.pdf) 7. 2026-09-21 HKEXnews [(1) FORMULATION OF THE 2026 H SHARE AWARD SCHEME; AND (2) AMENDMENTS TO THE ARTICLES OF ASSOCIATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0921/2026092101739.pdf) 8. 2026-09-07 HKEXnews [VOLUNTARY ANNOUNCEMENT POSITIVE RESULTS FROM A PHASE IIA PROOF-OF-CONCEPT CLINICAL TRIAL OF RIFAQUIZINONE (TNP-2092) FOR THE TREATMENT OF PROSTHETIC JOINT INFECTION AND INITIATION OF A MULTI-CENTER PHASE IIB CLINICAL TRIAL](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0907/2026090700043.pdf) 9. 2026-08-26 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0826/2026082600498.pdf) 10. 2026-06-29 HKEXnews [POLL RESULTS OF THE ANNUAL SHAREHOLDERS' MEETING HELD ON MONDAY, JUNE 29, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0629/2026062901775.pdf) 11. 2026-06-08 HKEXnews [NOTICE OF ANNUAL SHAREHOLDERS' MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0608/2026060802154.pdf) 12. 2026-06-08 HKEXnews [CIRCULAR OF ANNUAL SHAREHOLDERS' MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0608/2026060802070.pdf) 13. 2026-06-08 HKEXnews [(1) AMENDMENTS TO THE ARTICLES OF ASSOCIATION; (2) NO DISTRIBUTION OF FINAL DIVIDENDS; AND (3) CHANGES IN COMPOSITION OF SPECIAL COMMITTEE UNDER THE BOARD](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0608/2026060801960.pdf) 14. 2026-06-08 HKEXnews [Letter to Non-Registered Holders - Arrangement of Electronic Dissemination of Corporate Communications](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0608/2026060801940.pdf) 15. 2026-06-08 HKEXnews [Letter to Registered Shareholders - Arrangements on Electronic Dissemination of Corporate Communications](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0608/2026060801838.pdf) 16. 2026-06-05 HKEXnews [RESIGNATION OF NON-EXECUTIVE DIRECTOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0605/2026060501798.pdf) 17. 2026-05-21 HKEXnews [ANNOUNCEMENT OF ALLOTMENT RESULTS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0521/2026052101298.pdf) 18. 2026-05-20 HKEXnews [Terms of Reference for the Nomination Committee of the Board of Directors](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0521/2026052100011.pdf) 19. 2026-05-20 HKEXnews [Terms of Reference for the Remuneration and Appraisal Committee of the Board of Directors](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0521/2026052100009.pdf) 20. 2026-05-20 HKEXnews [Terms of Reference for the Audit Committee of the Board of Directors](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0521/2026052100007.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:6872 on TradingView](https://www.tradingview.com/symbols/HKEX-6872/). ## Listing details TenNor Therapeutics Suzhou Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 6872, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: TenNor Therapeutics Suzhou Ltd. - **Ticker**: 6872 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Biotechnology - **ISIN**: CNE100007KG6 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-6872/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/tennor-therapeutics-suzhou/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "TenNor Therapeutics Suzhou (6872) stock and investor profile", 2026-10-31, https://aibio.space/companies/tennor-therapeutics-suzhou/